Leerink Partners upgrades, downgrades and price targets
Leerink Partners has published 918 rating actions on 434 companies in the Quantisnow ratings feed since June 2021: 102 upgrades, 128 downgrades and 276 initiations. Its most recent action on NPCE was on Nov 13, 2026: Leerink Partners downgrades to Market Perform from Outperform, price target $7. Going by its latest rating on each stock, Leerink Partners rates 71% of the companies it covers Buy or an equivalent and 0% Sell or an equivalent. Health Care is the sector it rates most often.
The desk was SVB Leerink, then SVB Securities, and became Leerink Partners in 2023. Ratings under the earlier names are included here.
- Rating actions
- 918
- Stocks rated
- 434
- Upgrades
- 102
- Downgrades
- 128
Latest Leerink Partners rating actions
- Nov 13, 2026NPCE
- Nov 13, 2026ENGN
- Nov 5, 2026VCYT
- Oct 20, 2026KZIA
- Oct 12, 2026VERA
- Oct 12, 2026QTTB
- Oct 12, 2026NKTR
- Oct 12, 2026EQ
- Oct 12, 2026CNTB
- Oct 7, 2026CRBU
- Oct 5, 2026ZNTL
- Oct 5, 2026ORIC
- Oct 5, 2026BMY
- Sep 21, 2026VRTX
- Sep 18, 2026ENTX
- Sep 18, 2026ELOX
- Sep 14, 2026PTCT
- Sep 14, 2026RYTM
- Sep 14, 2026LRMR
- Sep 14, 2026PTCT
- Sep 9, 2026VTRS
- Sep 9, 2026TEVA
- Sep 9, 2026PHAT
- Sep 9, 2026PCRX
- Sep 9, 2026NAUT
- Sep 9, 2026HROW
- Sep 9, 2026BLCO
- Sep 9, 2026AMRX
- Sep 9, 2026COLL
- Sep 9, 2026ANIP
- Aug 31, 2026ATTO
- Aug 14, 2026LGND
- Aug 12, 2026SMMT
- Aug 11, 2026IPHA
- Aug 7, 2026AKBA
- Aug 7, 2026HALO
- Aug 6, 2026EXEL
- Aug 6, 2026PODD
- Aug 4, 2026REPL
- Jul 30, 2026HUM
Recent upgrades
- ENGN Outperform · $5Nov 13, 2026
- SMMT Market Perform · $13Aug 12, 2026
- IPHA Outperform · $4Aug 11, 2026
- HALO Outperform · $110Aug 7, 2026
- REPL Outperform · $17Aug 4, 2026
- HUM Outperform · $513Jul 30, 2026
- GOSS Outperform · $1Jul 28, 2026
- EW Outperform · $101Jul 24, 2026
- EQ Outperform · $6May 28, 2026
- ANTX Outperform · $9May 14, 2026
Recent downgrades
- NPCE Market Perform · $7Nov 13, 2026
- VCYT Market Perform · $35Nov 5, 2026
- CRBU Market Perform · $1Oct 7, 2026
- BMY Market Perform · $59Oct 5, 2026
- AKBA Market Perform · $1Aug 7, 2026
- EXEL Market Perform · $52Aug 6, 2026
- PODD Market Perform · $145Aug 6, 2026
- GILD Market Perform · $127Jul 21, 2026
- PRCT Market Perform · $29Jun 11, 2026
- FULC Market Perform · $4Jun 2, 2026
Recent initiations
- KZIA Outperform · $30Oct 20, 2026
- VERA Market Perform · $34Oct 12, 2026
- QTTB Outperform · $40Oct 12, 2026
- NKTR Outperform · $130Oct 12, 2026
- ORIC Outperform · $26Oct 5, 2026
- VRTX Outperform · $594Sep 21, 2026
- ENTX Outperform · $9Sep 18, 2026
- ELOX Outperform · $32Sep 18, 2026
- VTRS Outperform · $20Sep 9, 2026
- TEVA Outperform · $45Sep 9, 2026
Stocks Leerink Partners rates most
| Stock | Latest rating | Price target | Actions | Last action |
|---|---|---|---|---|
| Market Perform | $641 | 9 | May 18, 2026 | |
| Outperform | $594 | 7 | Sep 21, 2026 | |
| Market Perform | $17 | 7 | Feb 26, 2024 | |
| Outperform | $26 | 7 | Mar 9, 2022 | |
| Outperform | $4 | 6 | Aug 11, 2026 | |
| Outperform | $110 | 6 | Aug 7, 2026 | |
| Outperform | $17 | 6 | Aug 4, 2026 | |
| Outperform | $101 | 6 | Jul 24, 2026 | |
| Outperform | $206 | 6 | Nov 22, 2024 | |
| Market Perform | $10 | 6 | Aug 6, 2024 | |
| Outperform | $62 | 6 | Jul 24, 2024 | |
| Market Perform | $9 | 6 | Mar 1, 2022 | |
| Outperform | $513 | 5 | Jul 30, 2026 | |
| Market Perform | $127 | 5 | Jul 21, 2026 | |
| Outperform | $34 | 5 | Nov 20, 2025 | |
| Outperform | $28 | 5 | Jul 8, 2025 | |
| Outperform | $25 | 5 | Nov 7, 2024 | |
| Outperform | $39 | 5 | Nov 6, 2024 | |
| Outperform | $45 | 5 | Apr 25, 2024 | |
| Outperform | $37 | 5 | Mar 6, 2024 | |
| Outperform | $78 | 5 | Dec 13, 2023 | |
| Outperform | $170 | 5 | May 30, 2023 | |
| Market Perform | $40 | 5 | May 12, 2023 | |
| Underperform | $93 | 5 | Feb 24, 2023 | |
| Outperform | $270 | 5 | Oct 4, 2022 | |
| Outperform | $23 | 5 | Aug 9, 2022 | |
| Outperform | $102 | 5 | Jun 6, 2022 | |
| Mkt Perform | $7 | 5 | May 23, 2022 | |
| Mkt Perform | $55 | 5 | May 23, 2022 | |
| Outperform | $268 | 5 | Mar 3, 2022 | |
| Outperform | $65 | 5 | Mar 2, 2022 | |
| Outperform | $70 | 5 | Feb 24, 2022 | |
| Market Perform | $68 | 5 | Feb 9, 2022 | |
| Market Perform | $35 | 4 | Nov 5, 2026 | |
| Outperform | $6 | 4 | Oct 12, 2026 | |
| Outperform | $8 | 4 | Oct 5, 2026 | |
| Market Perform | $145 | 4 | Aug 6, 2026 | |
| Outperform | $1 | 4 | Jul 28, 2026 | |
| Market Perform | $29 | 4 | Jun 11, 2026 | |
| Market Perform | $4 | 4 | Jun 2, 2026 | |
| Outperform | $9 | 4 | May 14, 2026 | |
| Outperform | $25 | 4 | Apr 29, 2026 | |
| Market Perform | $113 | 4 | Feb 2, 2026 | |
| Market Perform | $14.50 | 4 | Dec 29, 2025 | |
| Outperform | $160 | 4 | Dec 3, 2025 | |
| Outperform | $73 | 4 | Sep 12, 2025 | |
| Outperform | $90 | 4 | Feb 7, 2025 | |
| Market Perform | $47 | 4 | Sep 3, 2024 | |
| Market Perform | $97 | 4 | May 6, 2024 | |
| Outperform | $8 | 4 | Feb 26, 2024 |
Every stock with three or more Leerink Partners ratings (133)
- AMGN
- ALVR
- A
- TRHC
- SGEN
- BGNE
- AMRN
- ALGS
- MDRX
- AHCO
- OSH
- SWAV
- THC
- INSP
- MIRM
- LHCG
- NPCE
- ENGN
- QTTB
- NKTR
- BMY
- PTCT
- EXEL
- UNH
- JNJ
- SYK
- NVST
- BMRN
- AUPH
- ACHC
- TRVI
- MNKD
- LLY
- ABCL
- RAPT
- CYRX
- MASS
- ABT
- ARVN
- RCKT
- ITOS
- CMPX
- ELEV
- NRIX
- PLRX
- GMAB
- CVS
- LVTX
- MYGN
- PRTC
- WAT
- HIMS
- ACCD
- TSVT
- AGL
- FDMT
- QTRX
- PHR
- LNTH
- HZNP
- CFRX
- SBTX
- AMYT
- RXDX
- RXRX
- GMTX
- HCAT
- AXSM
- KPTI
- NVRO
- ONEM
- EXAS
- AMED
- XERS
- ALNY
- ABMD
- ANTM
- ISO
- VCRA
- PRVA
- RCUS
- TCRR
- ADAP
Sectors Leerink Partners rates
- Health Care847
- Technology33
- Consumer Discretionary26
- Industrials7
- Consumer Staples4
- Finance1
Rating actions by year
| Year | All | Up | Down | New |
|---|---|---|---|---|
| 2026 | 90 | 15 | 16 | 50 |
| 2025 | 88 | 22 | 30 | 35 |
| 2024 | 126 | 19 | 26 | 71 |
| 2023 | 56 | 15 | 16 | 23 |
| 2022 | 212 | 22 | 21 | 38 |
| 2021 | 346 | 9 | 19 | 59 |
Questions about Leerink Partners ratings
- How many stocks does Leerink Partners cover?
- Leerink Partners has rated 434 companies in the Quantisnow feed since June 2021, across 918 rating actions.
- What was Leerink Partners's latest upgrade?
- On Nov 13, 2026, Leerink Partners upgrades to Outperform from Market Perform, price target $5 on ENGN.
- What was Leerink Partners's latest downgrade?
- On Nov 13, 2026, Leerink Partners downgrades to Market Perform from Outperform, price target $7 on NPCE.
- Does Leerink Partners upgrade or downgrade more often?
- Leerink Partners has made 102 upgrades and 128 downgrades in the feed, so 44% of its rating changes were upgrades.
Other analyst firms
- Morgan Stanley5,645
- BofA Securities4,136
- Wells Fargo3,654
- Barclays3,651
- Citigroup3,492
- Raymond James3,400
- Jefferies3,156
- Goldman Sachs3,096
- UBS2,894
- Piper Sandler2,696
- TD Cowen2,569
- RBC Capital Markets2,406
- Deutsche Bank2,231
- KeyBanc Capital Markets1,966
- Wolfe Research1,903
- BMO Capital Markets1,784
- Truist Securities1,685
- Stifel1,658
- Needham1,592
- Oppenheimer1,575
- Mizuho1,563
- Evercore ISI1,410
- Robert W. Baird1,399
- H.C. Wainwright1,232
From rating actions in the Quantisnow feed since June 2021. Includes ratings published as SVB Leerink, SVB Securities. Counts refresh every six hours. See also today's analyst upgrades and the live ratings feed.